Back to UBS Group AG UBS Group AG

CURXCURX
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in CURANEX PHARMACEUTICALS INC

UBS Group AG holds 1,506 shares of CURX (CURANEX PHARMACEUTICALS INC), worth $400 as of 2026-Q2. The position was decreased (-81.2% shares).

Current Value

$400

Current Shares

1,506

Total Value Change

-$46,051

Total Shares Change

-63,010

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1,506
-81.2%
$4000.0%$0.27
0
2026-Q1
Decreased
7,995
-38.5%
$4,0850.0%$0.46
0
2025-Q4
Decreased
12,991
-79.9%
$4,3000.0%$0.34
0
2025-Q3
New
64,516
-
$46,4510.0%$0.79
31

Other major holders of CURX: GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, XTX Topco Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used